For example, high proliferation rate measured by Ki67 expression and high grade have greater prognostic value and are more predictive of chemotherapy response in ER-positive cancers than in triple-negative breast cancers (TNBCs) (ER-, PR- and HER2-negative). Here, ESR1 is linked to triple-negative breast carcinoma.